LRLayal Rached
Layal Rached
*This is an algorithmically generated author record based on publicly available information.
Research Subjects
Layal Rached has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Viansone
Department of Cancer Medicine, Gustave Roussy, Villejuif, France
2 shared publications - Capucine Baldini
Département d’Innovation Thérapeutique et d’Essais Précoces (DITEP), Gustave Roussy Cancer Campus, Université Paris-Saclay, 94805 Villejuif, France
2 shared publications - Joana Ribeiro
Medical Oncology Unit, Gustave Roussy, Paris, France
2 shared publications - Stephane Champiat
Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA
2 shared publications A. Laparra
1 shared publicationA. Larive
1 shared publication
Latest Publications
- Open Access
- 8 August 2024
- Published by Elsevier in ESMO Real World Data and Digital Oncology
- Vol. 5
Real-world safety and effectiveness of neoadjuvant chemotherapy combination with pembrolizumab in triple-negative breast cancer
- 8 August 2024
- Published by Elsevier in ESMO Real World Data and Digital Oncology
- Vol. 5
Open AccessReal-world safety and effectiveness of neoadjuvant chemotherapy combination with pembrolizumab in triple-negative breast cancer
- Top Cited PapersOpen Access
- 4 May 2024
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 127, 102751
Toxicity of immunotherapy combinations with chemotherapy across tumor indications: Current knowledge and practical recommendations
- 4 May 2024
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 127, 102751
Top Cited PapersOpen AccessToxicity of immunotherapy combinations with chemotherapy across tumor indications: Current knowledge and practical recommendations
- 5 November 2023
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 14 (8) , S44-S45
Incidence of adverse events in older patients treated with Chemotherapy+Immunotherapy combinations
- 5 November 2023
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 14 (8) , S44-S45
Incidence of adverse events in older patients treated with Chemotherapy+Immunotherapy combinations
- Open Access
Bridging the gap: addressing disparities of access to oncology clinical trials in the geriatric population